Alkem Labs Generic Topiramate Receives Approval in US
Alkem Labs Generic Elagolix Receives Tentative Approval in US
The United States Food and Drug Administration (US FDA) released a detailed report today (April 10) on the ten procedural observations it had made on Alkem Laboratories' Baddi unit last month.
FDA Issues form 483 to Alkem Laboratories Limited
Alkem Laboratories sinks 3 percent on US FDA`s 10 observations for Himachal unit
SKCDA asks Alkem to recall anti-reflux drug PAN-D which are in circulation with fake batch numbers
Alkem Lab`s Generic Mirabegro Receives Approval in the U.S.
Heritage Global Partners, New Mill Capital, Federal Equipment Company